ASCO HR-Positive, HER2-Negative Metastatic Breast Cancer Pocket Guide Cover

HR-Positive, HER2-Negative Metastatic Breast Cancer GUIDELINES Pocket Guide

Endocrine Treatment and Targeted Therapy

Approved By

American Society of Clinical Oncology

Digital Subscription $0.00 Add to Library
Print $9.95 Add to Cart
Free Sample

Digital version available at no cost – click here to access

The digital version of the American Society of Clinical Oncology HR-Positive, HER2-Negative Metastatic Breast Cancer GUIDELINES contains all the same great information found in the pocket guide and can be accessed on mobile devices and online:

  • ASCO members receive free digital access at www.asco.org/guideline-pocket-cards
  • Price: FREE
    • Subscribe to additional guideline titles for discounted rates
  • Includes automatic updates during the term of your subscription
  • CPT® and ICD10 codes can be added to certain guidelines for an additional fee
  • Supported platforms
    • iPhone and iPad
    • Android phones and tablets
    • Online (internet connection required)
  • Content on the Guideline Central mobile app accessible without an internet connection
    • Access to additional guideline summaries, clinical calculators, and more

For mobile access, download the free app from the App Store or Google Play and use the same email address and password as the website to login.

For individual use only; contact us for group and site licenses.

The HR-positive, HER2-Negative Metastatic Breast Cancer – Endocrine and Targeted Therapy Pocket Guide is based on the latest guidelines of the American Society of Clinical Oncology and was developed with their collaboration. It contains graded recommendations for endocrine and targeted treatment of hormone receptor-positive, HER2-negative metastatic breast cancer including a management algorithm.

  • Multifold
  • 8 pages
  • 80# Diamond Silk Cover with Satin Aqueous Coating
  • 4.25″ x 7
  • Introduction
  • Figure
    • Algorithm for Endocrine Treatment and Targeted Therapy for HR positive, HER2 negative Metastatic Breast Cancer

Founded in 1964, the American Society of Clinical Oncology is the world's leading professional organization for physicians and oncology professionals caring for people with cancer.

  • Guideline Pricing

  • Single Title
    $4.99 / year
  • Any 5 Titles
    $23.99 / year
  • Any 10 Titles
    $41.99 / year
  • Any 35 Titles
    $74.99 / year
  • All Available Titles
    $169.99 / year

To get started, log in or create your free account Create Account